Cargando…

Comments on Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran

Detalles Bibliográficos
Autores principales:	Karimi-Sari, H., Mousavi-Naeini, S.M., Khonche, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Avicenna Organ Transplantation Institute 2017
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347407/ https://www.ncbi.nlm.nih.gov/pubmed/28299029

Ejemplares similares

Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran
por: Moghaddasifar, I., et al.
Publicado: (2016)

Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran
por: AMIRKALALI, Bahareh, et al.
Publicado: (2014)

Body Composition and Non-alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2016)

Eyeing non-alcoholic fatty liver disease: The noninvasive way
por: Gude, Dilip
Publicado: (2011)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Lean non-alcoholic fatty liver disease: do not forget diabetes
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2019)

Noninvasive Imaging for the Evaluation of Non-Alcoholic Fatty Liver Disease Spectrum
por: Liu, Qianjiao, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease, diabetes medications and blood pressure
por: Ilias, Ioannis, et al.
Publicado: (2021)

Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
por: Jeong, Seogsong, et al.
Publicado: (2023)

Multipronged Approach to Assess Risk Factors for Non-alcoholic Fatty Liver Disease
por: Hidrus, Aizuddin, et al.
Publicado: (2022)

Comments on Relationship between the High Fatty Liver Index and Risk of Fracture
por: Lai, Shih-Wei, et al.
Publicado: (2023)

Comment on “Prevalence of Occult Hepatitis B Virus Infection in Hemodialysis Patients in Isfahan, Iran”
por: Li Cavoli, Gioacchino, et al.
Publicado: (2017)

Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
por: Abbas, Tahany, et al.
Publicado: (2020)

Assessing causal relationships between COVID-19 and non-alcoholic fatty liver disease
por: Liu, Dong, et al.
Publicado: (2022)

Comments on “Iran Hospital Accreditation System”
por: MOSADEGHRAD, Ali Mohammad
Publicado: (2016)

Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
por: Hong, Jian-Guo, et al.
Publicado: (2022)

Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Li, Xia, et al.
Publicado: (2018)

Comments on Relationship between the High Fatty Liver Index and Risk of Fracture: Reply
por: Kim, Min-Ji, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease and the risk of dementia: A meta-analysis of cohort studies
por: Lu, Li-Yu, et al.
Publicado: (2022)

Comment on “Zoonotic and Non-zoonotic Parasites of Wild Rodents in Turkman Sahra, Northeastern Iran”
por: SADJJADI, Seyed Mahmoud
Publicado: (2018)

Comment on “Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp”
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2017)

Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Bibbò, Stefano, et al.
Publicado: (2018)

Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
por: Patoulias, Dimitrios, et al.
Publicado: (2019)

Liraglutide for non-alcoholic fatty liver disease in children and adolescents: has a new era arrived?
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Comment on: "Economic Burden of Thalassemia Major in Iran, 2015"
por: Rezaei, Satar, et al.
Publicado: (2016)

Comment on: Need for Primary Prevention for Skin Cancers in Iran
por: Nahar, Vinayak K, et al.
Publicado: (2016)

Response to: Comment on “Zoonotic and Non-zoonotic Parasites of Wild Rodents in Turkman Sahra, Northeastern Iran”
por: GHOLIPOURY, Monireh, et al.
Publicado: (2018)

Comments to Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Guan, Yong-Song
Publicado: (2014)

Comment on “binge drinking and alcohol prices”
por: Xuan, Ziming, et al.
Publicado: (2016)

Prevention and Control of Non-Communicable Diseases in Iran: A Window of Opportunity for Policymakers
por: MOUSAVI, Seyyed Meysam, et al.
Publicado: (2014)

Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
por: Patoulias, Dimitrios, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease in patients with inflammatory bowel disease might boost cardiovascular disease burden
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
por: Jeong, Seogsong, et al.
Publicado: (2022)

Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease
por: Patoulias, Dimitrios, et al.
Publicado: (2018)

Prevalence of Disability in Iran
por: SOLTANI, Shahin, et al.
Publicado: (2015)

Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
por: Lee, Hye Won
Publicado: (2023)

Comment on “The Prevalence of Skilled Birth Attendant Utilization and Its Correlates in North West Ethiopia”
por: Shivalli, Siddharudha, et al.
Publicado: (2015)

Comment on: Myopia, its prevalence, current therapeutic strategy and recent developments: A review
por: Dwivedi, Anamika
Publicado: (2023)

Is Ki-67 a prognostic factor for post-operation survival in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma?
por: Li, Changcan, et al.
Publicado: (2022)

Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
por: Lee, Jun-Hyuk, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kjri3g7ah0hu7raenbu9u8scv4